ZA983997B - Triazole derivatives, process for their preparation and pharmaceutical compositions containing them. - Google Patents
Triazole derivatives, process for their preparation and pharmaceutical compositions containing them.Info
- Publication number
- ZA983997B ZA983997B ZA9803997A ZA983997A ZA983997B ZA 983997 B ZA983997 B ZA 983997B ZA 9803997 A ZA9803997 A ZA 9803997A ZA 983997 A ZA983997 A ZA 983997A ZA 983997 B ZA983997 B ZA 983997B
- Authority
- ZA
- South Africa
- Prior art keywords
- preparation
- pharmaceutical compositions
- compositions containing
- triazole derivatives
- triazole
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/14—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Child & Adolescent Psychology (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Nutrition Science (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9705850A FR2763337B1 (fr) | 1997-05-13 | 1997-05-13 | Nouveaux derives du triazole, un procede pour leur preparation et compositions pharmaceutiques les contenant |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA983997B true ZA983997B (en) | 1999-11-12 |
Family
ID=9506830
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9803997A ZA983997B (en) | 1997-05-13 | 1998-05-12 | Triazole derivatives, process for their preparation and pharmaceutical compositions containing them. |
Country Status (35)
Country | Link |
---|---|
EP (1) | EP0984960B1 (xx) |
JP (1) | JP2001524980A (xx) |
KR (1) | KR20010012541A (xx) |
CN (1) | CN1263528A (xx) |
AR (1) | AR011729A1 (xx) |
AT (1) | ATE232207T1 (xx) |
AU (1) | AU725530B2 (xx) |
BR (1) | BR9811465A (xx) |
CA (1) | CA2289573A1 (xx) |
CO (1) | CO4940485A1 (xx) |
CZ (1) | CZ289484B6 (xx) |
DE (1) | DE69811223T2 (xx) |
DK (1) | DK0984960T3 (xx) |
DZ (1) | DZ2486A1 (xx) |
EE (1) | EE9900524A (xx) |
ES (1) | ES2190081T3 (xx) |
FR (1) | FR2763337B1 (xx) |
GT (1) | GT199800068A (xx) |
HR (1) | HRP980258B1 (xx) |
HU (1) | HUP0002763A3 (xx) |
ID (1) | ID22911A (xx) |
IL (1) | IL132903A0 (xx) |
IS (1) | IS5235A (xx) |
NO (1) | NO995513L (xx) |
NZ (1) | NZ500637A (xx) |
PL (1) | PL336772A1 (xx) |
RU (1) | RU2175323C2 (xx) |
SI (1) | SI0984960T1 (xx) |
SK (1) | SK154299A3 (xx) |
TR (1) | TR199902795T2 (xx) |
TW (1) | TW396155B (xx) |
UY (1) | UY24997A1 (xx) |
WO (1) | WO1998051686A1 (xx) |
YU (1) | YU57999A (xx) |
ZA (1) | ZA983997B (xx) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2802530B1 (fr) * | 1999-12-17 | 2002-02-22 | Sanofi Synthelabo | Nouveaux derives amino substitues ramifies du 3-amino-1-phenyl-1h[1,2,4]triazole, procedes pour leur preparation et compositions pharmaceutiques les contenant |
CA2420727A1 (en) * | 2000-10-26 | 2002-05-02 | Sanofi-Synthelabo | Triazole derivatives and pharmaceutical compositions comprising them |
FR2815963B1 (fr) * | 2000-10-26 | 2003-02-28 | Sanofi Synthelabo | Nouveaux derives du triazole et les compositions pharmaceutiques les contenant |
HUP0004741A2 (hu) * | 2000-11-28 | 2002-12-28 | Sanofi-Synthelabo | Kémiai eljárás tiazolszármazékok előállítására és új intermedier |
CA2463441A1 (en) * | 2001-10-12 | 2003-05-08 | Bayer Pharmaceuticals Corporation | Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity |
EP1314733A1 (en) | 2001-11-22 | 2003-05-28 | Aventis Pharma Deutschland GmbH | Indole-2-carboxamides as factor Xa inhibitors |
EP1479677A1 (en) * | 2003-05-19 | 2004-11-24 | Aventis Pharma Deutschland GmbH | New indole derivatives as factor xa inhibitors |
EP1532980A1 (en) | 2003-11-24 | 2005-05-25 | Novo Nordisk A/S | N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes |
GB0403038D0 (en) * | 2004-02-11 | 2004-03-17 | Novartis Ag | Organic compounds |
CA2676222A1 (en) * | 2007-01-26 | 2008-07-31 | Merck & Co., Inc. | Substituted aminopyrimidines as cholecystokinin-1 receptor modulators |
JP5401544B2 (ja) * | 2008-07-15 | 2014-01-29 | ノバルティス アーゲー | Dgat1阻害剤としてのヘテロアリール誘導体 |
KR101444559B1 (ko) * | 2009-06-09 | 2014-09-26 | 액테리온 파마슈티칼 리미티드 | 불화 아미노트리아졸 유도체 |
EP2490658A1 (de) * | 2009-10-22 | 2012-08-29 | Henkel AG & Co. KGaA | Zusammensetzung zur formgebung keratinischer fasern enthaltend mit propylenoxid modifizierte stärke |
CN106928147A (zh) * | 2017-03-14 | 2017-07-07 | 华东师范大学 | 三环二萜类似物及其制备方法、及其在制备抗前列腺癌药物中的应用 |
CN107271623A (zh) * | 2017-07-27 | 2017-10-20 | 青岛啤酒股份有限公司 | 基于人体饱腹感的啤酒可饮性评价方法 |
IL291985A (en) | 2019-10-07 | 2022-06-01 | Kallyope Inc | gpr119 agonists |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2701708B1 (fr) * | 1993-02-19 | 1995-05-19 | Sanofi Elf | Dérivés de 2-amido-4-phénylthiazoles polysubstitués, procédé de préparation, composition pharmaceutique et utilisation de ces dérivés pour la préparation d'un médicament. |
FR2703995B1 (fr) * | 1993-04-16 | 1995-07-21 | Sanofi Elf | 5-acylamino 1,2,4-thiadiazoles, leur preparation et compositions pharmaceutiques en contenant. |
-
1997
- 1997-05-13 FR FR9705850A patent/FR2763337B1/fr not_active Expired - Fee Related
-
1998
- 1998-05-06 YU YU57999A patent/YU57999A/sh unknown
- 1998-05-06 ES ES98924383T patent/ES2190081T3/es not_active Expired - Lifetime
- 1998-05-06 CZ CZ19994006A patent/CZ289484B6/cs not_active IP Right Cessation
- 1998-05-06 JP JP54885398A patent/JP2001524980A/ja not_active Ceased
- 1998-05-06 PL PL98336772A patent/PL336772A1/xx unknown
- 1998-05-06 AT AT98924383T patent/ATE232207T1/de not_active IP Right Cessation
- 1998-05-06 SI SI9830372T patent/SI0984960T1/xx unknown
- 1998-05-06 CO CO98024703A patent/CO4940485A1/es unknown
- 1998-05-06 BR BR9811465-4A patent/BR9811465A/pt not_active IP Right Cessation
- 1998-05-06 DK DK98924383T patent/DK0984960T3/da active
- 1998-05-06 TR TR1999/02795T patent/TR199902795T2/xx unknown
- 1998-05-06 IL IL13290398A patent/IL132903A0/xx unknown
- 1998-05-06 HU HU0002763A patent/HUP0002763A3/hu unknown
- 1998-05-06 DZ DZ980096A patent/DZ2486A1/xx active
- 1998-05-06 SK SK1542-99A patent/SK154299A3/sk unknown
- 1998-05-06 CN CN98807175A patent/CN1263528A/zh active Pending
- 1998-05-06 KR KR1019997010496A patent/KR20010012541A/ko not_active Application Discontinuation
- 1998-05-06 ID IDW991374A patent/ID22911A/id unknown
- 1998-05-06 AU AU76599/98A patent/AU725530B2/en not_active Ceased
- 1998-05-06 EP EP98924383A patent/EP0984960B1/fr not_active Expired - Lifetime
- 1998-05-06 WO PCT/FR1998/000905 patent/WO1998051686A1/fr not_active Application Discontinuation
- 1998-05-06 CA CA002289573A patent/CA2289573A1/fr not_active Abandoned
- 1998-05-06 EE EEP199900524A patent/EE9900524A/xx unknown
- 1998-05-06 DE DE69811223T patent/DE69811223T2/de not_active Expired - Fee Related
- 1998-05-06 RU RU99125773/04A patent/RU2175323C2/ru not_active IP Right Cessation
- 1998-05-06 NZ NZ500637A patent/NZ500637A/xx unknown
- 1998-05-11 AR ARP980102152A patent/AR011729A1/es active IP Right Grant
- 1998-05-12 ZA ZA9803997A patent/ZA983997B/xx unknown
- 1998-05-12 UY UY24997A patent/UY24997A1/es not_active IP Right Cessation
- 1998-05-12 TW TW087107326A patent/TW396155B/zh active
- 1998-05-13 HR HR980258A patent/HRP980258B1/xx not_active IP Right Cessation
- 1998-05-20 GT GT199800068A patent/GT199800068A/es unknown
-
1999
- 1999-10-29 IS IS5235A patent/IS5235A/is unknown
- 1999-11-11 NO NO995513A patent/NO995513L/no not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0100431A3 (en) | Adamantana derivatives, pharmaceutical compositions comprising them and process for preparing them | |
HUP9700358A3 (en) | New oxazolidinon derivatives, process for their preparation and pharmaceutical compositions containing them | |
HUP0001508A3 (en) | 4-arylmethylene-2-imino-2,3-dihydrothiazole derivatives, their use, process for the preparation thereof and pharmaceutical compositions containing them | |
HUP9603494A3 (en) | Hydroxycarboxamide derivatives, pharmaceutical compositions containing them, process for the preparation thereof | |
ZA9811759B (en) | Novel indole derivatives, processes for their preparation, their use and pharmaceutical compositions containing them. | |
HUP9603495A3 (en) | 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-compounds, pharmaceutical compositions containing the same and process for their preparation | |
HUP0100225A3 (en) | Carboxamidothiazole derivatives, preparation, pharmaceutical compositions containing them | |
HUP9902455A3 (en) | 6-phenylpyridyl-2-amine derivatives, pharmaceutical compositions containing them | |
HUP9900625A3 (en) | Benzimidazole derivatives, pharmaceutical compositions containing them and process for preparing the compounds | |
IL135920A0 (en) | 2-aryl -8-oxodihydropurine derivative, process for the preparation thereof, pharmaceutical composition containing the same and intermediate therefor | |
HUP0000721A3 (en) | Gemcitabine derivatives, process for their preparation and pharmaceutical compositions containing them | |
HUP9802422A3 (en) | Substituted isoquinoline-3-carboxamide derivatives, process for producing them and pharmaceutical compositions containing them | |
HUP0004024A3 (en) | Azabenzimidazole-based compounds, process for their preparation and pharmaceutical composition thereof | |
HUP9900974A3 (en) | Heterocycle-condensed morphinoid derivatives, process for the preparation thereof, their use and pharmaceutical compositions containing them | |
HUP0001555A3 (en) | Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation | |
HUP0102215A3 (en) | Benzoylpyridazines, pharmaceutical compositions containing the same and process for their preparation | |
HUP9602635A2 (en) | 4-aciloxy-benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions containing them | |
HUP0201402A3 (en) | Bis-sulfonamides, process for their preparation and pharmaceutical compositions containing them | |
ZA983997B (en) | Triazole derivatives, process for their preparation and pharmaceutical compositions containing them. | |
HK1039122A1 (zh) | 取代的6-苄基-4-氧代嘧啶,其製備方法以及含該化合物的藥物組合物 | |
HUP9901485A3 (en) | Heterocyclylcarboxamide derivatives, pharmaceutical compositions containing the same, process for their preparation and their use | |
HUP9801089A3 (en) | Benzenesulfonamide derivatives, process for their preparation, pharmaceutical compositions containing them | |
HUP0003148A2 (en) | Cyanoguanidine derivatives, process for producing them and pharmaceutical compositions containing them | |
HUP0003150A2 (en) | Cyanoguanidine derivatives, process for producing them and pharmaceutical compositions containing them | |
HUP0104620A3 (en) | 2-phenylpyran-4-one derivatives, process for their preparation and medicaments containing them |